Literature DB >> 24521050

Cutaneous immunization: an evolving paradigm in influenza vaccines.

Harvinder S Gill1, Sang-Moo Kang, Fu-Shi Quan, Richard W Compans.   

Abstract

INTRODUCTION: Most vaccines are administered by intramuscular injection using a hypodermic needle and syringe. Some limitations of this procedure include reluctance to be immunized because of fear of needlesticks, and concerns associated with the safe disposal of needles after their use. Skin delivery is an alternate route of vaccination that has potential to be painless and could even lead to dose reduction of vaccines. Recently, microneedles have emerged as a novel painless approach for delivery of influenza vaccines via the skin. AREAS COVERED: In this review, we briefly summarize the approaches and devices used for skin vaccination, and then focus on studies of skin immunization with influenza vaccines using microneedles. We discuss both the functional immune response and the nature of this immune response following vaccination with microneedles. EXPERT OPINION: The cutaneous administration of influenza vaccines using microneedles offers several advantages: it is painless, elicits stronger immune responses in preclinical studies and could improve responses in high-risk populations. These dry formulations of vaccines provide enhanced stability, a property of high importance in enabling their rapid global distribution in response to possible outbreaks of pandemic influenza and newly emerging infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24521050      PMCID: PMC4009492          DOI: 10.1517/17425247.2014.885947

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  98 in total

1.  Coated microneedles for transdermal delivery.

Authors:  Harvinder S Gill; Mark R Prausnitz
Journal:  J Control Release       Date:  2006-10-24       Impact factor: 9.776

2.  Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.

Authors:  Glendie Marcelin; Hilliary M Bland; Nicholas J Negovetich; Matthew R Sandbulte; Ali H Ellebedy; Ashley D Webb; Yolanda S Griffin; Jennifer L DeBeauchamp; Janet E McElhaney; Richard J Webby
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

3.  Formulation of microneedles coated with influenza virus-like particle vaccine.

Authors:  Yeu-Chun Kim; Fu-Shi Quan; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  AAPS PharmSciTech       Date:  2010-07-30       Impact factor: 3.246

4.  Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.

Authors:  Marc Pearton; Sang-Moo Kang; Jae-Min Song; Yeu-Chun Kim; Fu-Shi Quan; Alexander Anstey; Matthew Ivory; Mark R Prausnitz; Richard W Compans; James C Birchall
Journal:  Vaccine       Date:  2010-06-08       Impact factor: 3.641

5.  Influenza vaccine: split-product versus whole-virus types--How do they differ.

Authors:  P A Gross; F A Ennis
Journal:  N Engl J Med       Date:  1977-03-10       Impact factor: 91.245

6.  Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes.

Authors:  Shohei Koyama; Taiki Aoshi; Takeshi Tanimoto; Yutaro Kumagai; Kouji Kobiyama; Takahiro Tougan; Kazuo Sakurai; Cevayir Coban; Toshihiro Horii; Shizuo Akira; Ken J Ishii
Journal:  Sci Transl Med       Date:  2010-03-31       Impact factor: 17.956

7.  Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Jae-Min Song; Hye Suk Hwang; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  Clin Vaccine Immunol       Date:  2013-07-17

Review 8.  Influenza vaccines based on virus-like particles.

Authors:  Sang-Moo Kang; Jae-Min Song; Fu-Shi Quan; Richard W Compans
Journal:  Virus Res       Date:  2009-04-15       Impact factor: 3.303

9.  Selective removal of stratum corneum by microdermabrasion to increase skin permeability.

Authors:  Harvinder S Gill; Samantha N Andrews; Senthilkumar K Sakthivel; Andrew Fedanov; Ifor R Williams; David A Garber; Frances H Priddy; Seth Yellin; Mark B Feinberg; Silvija I Staprans; Mark R Prausnitz
Journal:  Eur J Pharm Sci       Date:  2009-06-25       Impact factor: 4.384

10.  Local response to microneedle-based influenza immunization in the skin.

Authors:  Maria del Pilar Martin; William C Weldon; Vladimir G Zarnitsyn; Dimitrios G Koutsonanos; Hamed Akbari; Ioanna Skountzou; Joshy Jacob; Mark R Prausnitz; Richard W Compans
Journal:  mBio       Date:  2012-03-06       Impact factor: 7.867

View more
  12 in total

Review 1.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

Review 2.  Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future.

Authors:  Yotam Levin; Efrat Kochba; Ivan Hung; Richard Kenney
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.

Authors:  Nicola Luigi Bragazzi; Andrea Orsi; Filippo Ansaldi; Roberto Gasparini; Giancarlo Icardi
Journal:  Hum Vaccin Immunother       Date:  2016-05-31       Impact factor: 3.452

Review 4.  Mucosal vaccine delivery: Current state and a pediatric perspective.

Authors:  Akhilesh Kumar Shakya; Mohammed Y E Chowdhury; Wenqian Tao; Harvinder Singh Gill
Journal:  J Control Release       Date:  2016-02-06       Impact factor: 9.776

5.  Fabrication of microneedle patches with lyophilized influenza vaccine suspended in organic solvent.

Authors:  Yoo Chun Kim; Jeong Woo Lee; E Stein Esser; Haripriya Kalluri; Jessica C Joyce; Richard W Compans; Ioanna Skountzou; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2021-02-15       Impact factor: 4.617

6.  Induction of a robust immune response against avian influenza virus following transdermal inoculation with H5-DNA vaccine formulated in modified dendrimer-based delivery system in mouse model.

Authors:  Azadeh Bahadoran; Mehdi Ebrahimi; Swee Keong Yeap; Nikoo Safi; Hassan Moeini; Mohd Hair-Bejo; Mohd Zobir Hussein; Abdul Rahman Omar
Journal:  Int J Nanomedicine       Date:  2017-11-30

7.  Skin immunization by microneedle patch overcomes statin-induced suppression of immune responses to influenza vaccine.

Authors:  Elena V Vassilieva; Shelly Wang; Song Li; Mark R Prausnitz; Richard W Compans
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

8.  Size-dependent penetration of nanoemulsions into epidermis and hair follicles: implications for transdermal delivery and immunization.

Authors:  Rui Su; Wufa Fan; Qin Yu; Xiaochun Dong; Jianping Qi; Quangang Zhu; Weili Zhao; Wei Wu; Zhongjian Chen; Ye Li; Yi Lu
Journal:  Oncotarget       Date:  2017-06-13

9.  The adjuvant GLA-AF enhances human intradermal vaccine responses.

Authors:  Darrick Carter; Neal van Hoeven; Susan Baldwin; Yotam Levin; Efrat Kochba; Al Magill; Nathalie Charland; Nathalie Landry; Khin Nu; Aude Frevol; Jill Ashman; Zachary K Sagawa; Anna Marie Beckmann; Steven G Reed
Journal:  Sci Adv       Date:  2018-09-12       Impact factor: 14.136

10.  Skin vaccination with dissolvable microneedle patches incorporating influenza neuraminidase and flagellin protein nanoparticles induces broad immune protection against multiple influenza viruses.

Authors:  Ye Wang; Song Li; Chunhong Dong; Yao Ma; Yufeng Song; Wandi Zhu; Joo Kim; Lei Deng; Timothy L Denning; Sang-Moo Kang; Mark R Prausnitz; Bao-Zhong Wang
Journal:  ACS Appl Bio Mater       Date:  2021-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.